Calystegine B2CAS# 127414-85-1 |
- Calystegine B3
Catalog No.:BCN1880
CAS No.:178231-95-3
- Calystegine B4
Catalog No.:BCN1881
CAS No.:184046-85-3
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 127414-85-1 | SDF | Download SDF |
PubChem ID | 443000 | Appearance | Oil |
Formula | C7H13NO4 | M.Wt | 175.18 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2S,3R,4R)-8-azabicyclo[3.2.1]octane-2,3,4,5-tetrol | ||
SMILES | C1CC2(C(C(C(C1N2)O)O)O)O | ||
Standard InChIKey | FXFBVZOJVHCEDO-NMACYSKISA-N | ||
Standard InChI | InChI=1S/C7H13NO4/c9-4-3-1-2-7(12,8-3)6(11)5(4)10/h3-6,8-12H,1-2H2/t3?,4-,5+,6+,7?/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Calystegine B2 can inhibit the alpha-galactosidase and enzymes beta-glucosidase activities. |
Calystegine B2 Dilution Calculator
Calystegine B2 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 5.7084 mL | 28.5421 mL | 57.0841 mL | 114.1683 mL | 142.7104 mL |
5 mM | 1.1417 mL | 5.7084 mL | 11.4168 mL | 22.8337 mL | 28.5421 mL |
10 mM | 0.5708 mL | 2.8542 mL | 5.7084 mL | 11.4168 mL | 14.271 mL |
50 mM | 0.1142 mL | 0.5708 mL | 1.1417 mL | 2.2834 mL | 2.8542 mL |
100 mM | 0.0571 mL | 0.2854 mL | 0.5708 mL | 1.1417 mL | 1.4271 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Y-26763
Catalog No.:BCC7253
CAS No.:127408-31-5
- Y-27152
Catalog No.:BCC7254
CAS No.:127408-30-4
- Odoroside A
Catalog No.:BCC8224
CAS No.:12738-19-1
- chroman 1
Catalog No.:BCC1480
CAS No.:1273579-40-0
- Coclauril
Catalog No.:BCN6150
CAS No.:127350-68-9
- Rebaudioside G
Catalog No.:BCN7860
CAS No.:127345-21-5
- 2-Chloromethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine hydrochloride
Catalog No.:BCC8569
CAS No.:127337-60-4
- YLF-466D
Catalog No.:BCC4086
CAS No.:1273323-67-3
- PACAP 1-27
Catalog No.:BCC5726
CAS No.:127317-03-7
- Zamifenacin fumarate
Catalog No.:BCC7418
CAS No.:127308-98-9
- BRL 37344, sodium salt
Catalog No.:BCC6860
CAS No.:127299-93-8
- Balofloxacin
Catalog No.:BCC4892
CAS No.:127294-70-6
- Calystegine B1
Catalog No.:BCN1882
CAS No.:127414-86-2
- Conantokin-T
Catalog No.:BCC5977
CAS No.:127476-26-0
- VU 0360223
Catalog No.:BCC6159
CAS No.:1274859-33-4
- CNX1351
Catalog No.:BCC6375
CAS No.:1276105-89-5
- HS-173
Catalog No.:BCC5363
CAS No.:1276110-06-5
- PF-3644022
Catalog No.:BCC6136
CAS No.:1276121-88-0
- Fananserin
Catalog No.:BCC7440
CAS No.:127625-29-0
- Oleficin
Catalog No.:BCN1848
CAS No.:12764-54-4
- Cadherin Peptide, avian
Catalog No.:BCC1018
CAS No.:127650-08-2
- PF-4989216
Catalog No.:BCC6468
CAS No.:1276553-09-3
- 9alpha,11-Dihydroxydrim-7-en-6-one
Catalog No.:BCN7225
CAS No.:127681-58-7
- (2R)-5,7-Dimethoxyflavanone
Catalog No.:BCN7806
CAS No.:1277188-85-8
Synthesis and evaluation of calystegine B2 analogues as glycosidase inhibitors.[Pubmed:11701011]
J Org Chem. 2001 Nov 16;66(23):7604-14.
A practical synthesis of polyhydroxylated 6-oxa-nor-tropanes incorporating the essential structural features of calystegine B(2) from 5-deoxy-5-thioureido and 5-ureido-L-idofuranose precursors is presented. The methodology relies on the ability of pseudoamide-type nitrogen atoms (thiourea, urea, and carbamate) to undergo nucleophilic addition to the masked aldehyde group of the monosaccharide. The generated hemiaminal functionality may further undergo in situ intramolecular glycosidation to give the bicyclic aminoacetal compounds, the whole process being favored by the anomeric effect. A series of derivatives bearing different substituents at nitrogen has been prepared and screened against several glycosidases in comparison with xylonojirimycin-type piperidine analogues. Interestingly, strong and highly specific inhibition of bovine liver beta-glucosidase was observed for 6-oxacalystegine B(2) analogues incorporating aromatic pseudoaglyconic groups. On the basis of these data, a 1-azasugar inhibition mode is proposed for this family of glycomimetics.
Biological activities of the nortropane alkaloid, calystegine B2, and analogs: structure-function relationships.[Pubmed:8988598]
J Nat Prod. 1996 Dec;59(12):1137-42.
Calystegines, polyhydroxy nortropane alkaloids, are a recently discovered group of plant secondary metabolites believed to influence rhizosphere ecology as nutritional sources for soil microorganisms and as glycosidase inhibitors. Evidence is presented that calystegines mediate nutritional relationships under natural conditions and that their biological activities are closely correlated with their chemical structures and stereochemistry. Assays using synthetic (+)- and (-)-enantiomers of Calystegine B2 established that catabolism by Rhizobium meliloti, glycosidase inhibition, and allelopathic activities were uniquely associated with the natural, (+)-enantiomer. Furthermore, the N-methyl derivative of Calystegine B2 was not catabolized by R. meliloti, and it inhibited alpha-galactosidase, but not beta-glucosidase, whereas the parent alkaloid inhibits both enzymes. This N-methyl analog therefore could serve to construct a cellular or animal model for Fabry's disease, which is caused by a lack of alpha-galactosidase activity.
Executing and rationalizing the synthesis of a difluorinated analogue of a ring-expanded calystegine B2.[Pubmed:22148579]
J Org Chem. 2012 Jan 20;77(2):991-8.
A difluorinated analogue of a ring-expanded calystegine B(2) and some N-protected species were prepared via microwave-mediated transannular ring-opening of an epoxyketone. The diastereofacial selectivity of the epoxidation reaction, which delivers the key intermediate, and the regioselectivity of the transannular reactions were analyzed by density functional theory (DFT) methods. The epoxidation stereoselectivity arises from simple steric control, whereas the ring-closure reactions are subject to thermodynamic control.
Identification of the glycosidase inhibitors swainsonine and calystegine B2 in Weir vine (Ipomoea sp. Q6 [aff. calobra]) and correlation with toxicity.[Pubmed:7673932]
J Nat Prod. 1995 Jun;58(6):878-86.
The polyhydroxy alkaloid glycosidase inhibitors swainsonine [1] and Calystegine B2 [6] have been identified as constituents of the seeds of the Australian plant Ipomoea sp. Q6 [aff. calobra] (Weir vine) by gas chromatography-mass spectrometry and by their biological activity as inhibitors of specific glycosidases. This plant, which is known only from a small area of southern Queensland, has been reported to produce a neurological disorder when consumed by livestock. The extract of the seeds showed inhibition of alpha-mannosidase, beta-glucosidase, and alpha-galactosidase, consistent with the presence of 1 and alkaloids of the calystegine class. Histological examination of brain tissue from field cases of sheep and cattle poisoned by Weir vine showed lesions similar to those observed in animals poisoned by the swainsonine-containing poison peas (Swainsona spp.) of Australia and locoweeds (Astragalus and Oxytropis spp.) of North America. These results indicate that Weir vine poisoning is an additional manifestation of the induced lysosomal storage disease, mannosidosis, possibly exacerbated by inhibition of the enzymes beta-glucosidase and alpha-galactosidase by Calystegine B2. This is the first reported example of a single plant species capable of producing structurally distinct glycosidase inhibitors, namely, alkaloids of the indolizidine and nortropane classes.